Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Contract Manufacturing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • Suppliers
    • The Big 100
      • Archive – The Big 100 (2018)
    • Webinars
    • Whitepapers
    • Video
  • Leadership
    • Women in Medtech
    • 2020 Winners
    • 2019 Winners

Abbott, Medtronic go head-to-head at ADA conference

June 15, 2020 By Nancy Crotti

Dario Health touts patient progress using digital platform

Two new studies showed sustained improvements in blood glucose levels and blood pressure among users of the DarioHealth (Nasdaq: DRIO) digital therapeutic platform for chronic diseases, the company announced at the conference.

In the first study, Dario conducted a 12-month retrospective analysis of 9,200 non-insulin treated Type-2 diabetes (T2D) users of the Dario digital therapeutic platform for chronic disease. A subgroup of users who participated in hypertension management were also evaluated. Seventy-five percent of blood pressure subgroup started the study with either stage 1, stage 2, or hypertensive crisis blood pressure levels.

Results included the following:

  • The average ratio of high blood glucose events (180-400 mg/dL) was reduced by 26% and sustained during the full year.
  • Users gradually increased their rate of fasting (<126 mg/dL) measurements by 16% on average.
  • 71% of members using the hypertension therapeutic succeeded in reducing their systolic blood pressure by 8.1 mmHg and diastolic by 6.0 mmHg on average and 38% succeeded in reducing their blood pressure by one stage.

In the second study, Dario conducted a two-year retrospective analysis on T2D users of the Dario digital therapeutic platform for chronic disease. Among the results:

  • A group of 148 T2D non-insulin users consistently reduced their blood glucose average by 18% on average, equivalent to eA1c reduction of 1.42%, and sustained these values for 2 years.
  • A subset that started with average blood glucose levels >240 mg/dL (eA1c >10) reduced their average blood glucose and equivalent eA1c by 2.42%.

Behaviors play a big role in driving chronic disease outcomes, according to DarioHealth chief medical officer Dr. Omar Manejwala.

“These results demonstrate the extraordinary potential for our digital therapeutics to improve glycemic and blood pressure control, which are key drivers of cost and clinical outcome in diabetes and hypertension,” Manejwala said in a news release.

“The addition of our blood pressure management solution to Dario’s digital therapeutic platform has significantly enhanced our users’ ability to manage their chronic conditions and associated comorbidities,” added Rick Anderson, president & GM of DarioHealth for North America.

Next>>

Pages: 1 2 3 4 5 6 7 8 9

Related Articles Read More >

These medtech stocks performed the best in 2020
10 stories that grabbed the most reader attention in 2020
How Dexcom CEO Kevin Sayer is leading the company forward
3M debuts new silicone adhesive for longer, stronger wear

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Tweets by MedTechDaily

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • Drug Delivery Business News
  • Medical Tubing + Extrusion
  • About Us/Contact
  • Advertising
  • Subscribe to Enewsletter
  • Subscribe to Print Magazine

Copyright © 2021 WTWH Media, LLC. All Rights Reserved. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Contract Manufacturing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • Suppliers
    • The Big 100
      • Archive – The Big 100 (2018)
    • Webinars
    • Whitepapers
    • Video
  • Leadership
    • Women in Medtech
    • 2020 Winners
    • 2019 Winners